Finance

Lists
1733:TPE
Apex Biotechnology Corp
NT$32,05
+1,26%
(+0,40) 1D
24 Jul., 13:30:19 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
NT$31,65
High
NT$32,35
Low
NT$31,65
Mkt. cap
3,20 mjd
Avg. vol.
204,60 k
Volume
258,00 k
Dividend
4,06%
Quarterly dividend
NT$0,33
Ex-dividend date
09 Jun. 2026
P/E ratio
17,72
52-wk high
NT$38,70
52-wk low
NT$27,60
EPS
NT$1,81
Shares outstanding
99,69 m
No. of employees
641
Open
NT$31,65
High
NT$32,35
Low
NT$31,65
Mkt. cap
3,20 mjd
Avg. vol.
204,60 k
Volume
258,00 k
Dividend
4,06%
Quarterly dividend
NT$0,33
Ex-dividend date
09 Jun. 2026
P/E ratio
17,72
52-wk high
NT$38,70
52-wk low
NT$27,60
EPS
NT$1,81
Shares outstanding
99,69 m
No. of employees
641
News stories
From sources across the web
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Websiteapexbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
509,95 m
437,21 m
438,99 m
519,72 m
Cost of goods sold
373,05 m
330,39 m
306,63 m
344,06 m
Cost of revenue
373,05 m
330,39 m
306,63 m
344,06 m
Research and development expenses
36,96 m
35,94 m
36,02 m
37,23 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,59 m
57,27 m
62,79 m
60,29 m
Operating expense
93,64 m
98,80 m
99,12 m
88,45 m
Total operating expenses
466,69 m
429,19 m
405,75 m
432,51 m
Operating income
43,26 m
8,02 m
33,24 m
87,21 m
Other non operating income
360,00 k
775,00 k
894,00 k
191,00 k
EBT including unusual items
22,16 m
29,21 m
58,17 m
86,91 m
EBT excluding unusual items
-938,00 k
34,02 m
57,52 m
90,23 m
Income tax expense
-6,60 m
7,12 m
7,97 m
5,54 m
Effective tax rate
-29,80%
24,37%
13,70%
6,38%
Other operating expenses
-
-
-
-
Net income
28,65 m
22,14 m
50,08 m
81,28 m
Net profit margin
5,62%
5,06%
11,41%
15,64%
Earnings per share
-
-
-
-
Interest and investment income
5,69 m
139,00 k
1,49 m
219,00 k
Interest expense
-851,00 k
-835,00 k
-822,00 k
-829,00 k
Net interest expenses
4,84 m
-696,00 k
665,00 k
-610,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
55,93 m
20,24 m
45,47 m
99,16 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer